Cultivated Meat Ingredients Market Size & Share 2025 - 2034

Cultivated Meat Ingredients Market Size

The global cultivated meat ingredients market was valued at USD 177 million in 2024. The market is expected to grow from USD 184 million in 2025 to USD 531.8 million in 2034, at a CAGR of 3.3%, according to latest report published by Global Market Insights Inc.

• Cultivated meat ingredients represent a critical component of the cellular agriculture ecosystem, enabling the production of real meat from animal cells without traditional animal farming. These ingredients include growth media components (amino acids, growth factors, recombinant proteins), scaffolding materials (plant-based matrices, edible biomaterials), and processing aids essential for cell proliferation, differentiation, and tissue structuring. The technology leverages precision fermentation and bioprocess engineering to produce food-grade inputs that support muscle, fat, and connective tissue development in bioreactor systems. With strengthening regulatory frameworks and zero-waste bioeconomy mandates, ingredient manufacturers and cultivated meat producers are prioritizing animal-free, cost-effective formulations to achieve price parity with conventional meat while maintaining food safety and sustainability standards.
   
• The commercial cultivated meat production sector drives the largest demand for specialized ingredients, accounting for the majority of consumption. Cell culture media formulations require high-quality components including basal media, recombinant growth factors (FGF2, IGF-1, TGF-β), serum replacements (albumin alternatives, plant-derived protein hydrolysates), and micronutrients to support high cell densities with strong viability rates. This circular bioprocessing approach reduces dependency on expensive pharmaceutical-grade components while enabling scalable production infrastructure capable of supporting large bioreactor facilities.
   
• Stringent government support and regulatory approvals are accelerating the adoption of cultivated meat ingredient technologies across major markets. Regulatory clearances in Singapore, the United States under the joint framework, Israel, and advancing European Union novel food pathways validate the safety and commercial viability of animal-free ingredient formulations. Public funding initiatives—including the United Kingdom’s research hub investment, the loan guarantee for fermentation facilities, and Singapore’s Food Story R&D Programme—demonstrate governmental commitment to building domestic ingredient supply chains. These policy frameworks, combined with significant cumulative private investment to date, are driving manufacturers to scale production of recombinant proteins, plant-based scaffolds, and serum-free media components for diverse cultivated meat applications.
   

Cultivated Meat Ingredients Market Trends

• Technological advancement in precision fermentation and recombinant protein production is transforming the industry through implementation of microbial cell factories, continuous bioprocessing systems, and AI-driven strain optimization. Modern precision fermentation facilities are achieving significant improvements in recombinant growth factor production efficiency, while albumin alternatives from plant sources and microbial platforms demonstrate commercial viability. The development of thermostable growth factor variants with extended half-life enables media recycling and reduces consumption substantially, materially lowering ingredient requirements per unit of cultivated meat produced.
   
• Strengthening regulatory frameworks globally are establishing clear pathways for novel food ingredients and cultivated meat products, creating favorable conditions for ingredient suppliers. The joint regulatory framework in the United States, Singapore’s approvals for multiple cultivated products, and Israel’s clearances demonstrate regulatory acceptance of animal-free media components and scaffold materials. The European Union’s novel food regulation and ongoing safety assessments are standardizing requirements for recombinant proteins, plant-derived hydrolysates, and edible scaffolds, while government investments in research hubs and fermentation infrastructure are accelerating domestic ingredient manufacturing capacity and supply chain development.
   
• Evolving cost dynamics and media formulation strategies are reshaping demand patterns as the industry transitions from pharmaceutical-grade to food-grade ingredient specifications. Early-stage formulations relied on expensive serum and pharmaceutical recombinant proteins, while breakthrough serum-free media systems using plant protein hydrolysates, food-grade stabilizers, and optimized amino acid blends have achieved substantial cost reductions. Companies have demonstrated dramatic media cost improvements, with ingredient suppliers now focusing on bulk production of crop-derived feedstocks and recombinant proteins at industrial fermentation scales to serve commercial cultivated meat facilities targeting expanded annual output levels.
   
• Expanding applications in structured meat products and hybrid formulations are opening new segments for scaffold biomaterials and specialty ingredients. Whole-cut cultivated products require edible scaffolds with specific mechanical characteristics, high porosity with interconnected structures, and food-safe fabrication methods. Plant-based scaffolds, fungal mycelium structures, and alginate–gelatin composites are demonstrating commercial viability at scale. At the same time, hybrid products blending cultivated cells with plant-based matrices are creating immediate opportunities for functional ingredients such as heme proteins, cultivated fats, and binding agents that enhance sensory attributes while reducing overall ingredient requirements compared to fully cultivated products.
   

Cultivated Meat Ingredients Market Analysis

Based on ingredients, the market is segmented into growth media components, scaffolding materials, and processing aids & formulation. Growth media components generated USD 111.5 million revenue in 2024 and is anticipated to expand at a CAGR of 3.2% during 2025 to 2034, holding a market share of 63% in 2024.
 

• Growth media components dominate the cultivated meat ingredients market due to their essential role in cell proliferation and tissue development throughout the entire cultivation process. The advantages of growth media components stem from their comprehensive formulation including basal media nutrients, recombinant growth factors, amino acid supplements, and serum replacements that provide the biochemical environment necessary for animal cell survival, multiplication, and differentiation. These characteristics make growth media components particularly critical for commercial-scale cultivated meat production where consistent cell performance, high viability rates, and reproducible tissue quality are fundamental requirements for economic viability.
   
• Growth media components have established leadership through their versatility in meeting diverse cultivation requirements across multiple meat types and production systems. By utilizing specific formulation strategies and precision fermentation technologies, manufacturers can develop customized media blends with targeted functional properties such as enhanced cell density achievement, accelerated growth kinetics, and optimized differentiation pathways to match exact production specifications. This customization capability has enabled growth media components to capture approximately 63% of the total market, significantly outperforming scaffolding and processing aid categories in supporting the core biological processes that define cultivated meat production efficiency and product quality outcomes.

Learn more about the key segments shaping this market

Download Free PDF

Based on application, the market is segmented into poultry cultivation, seafood & fish cultivation, beef & red meat cultivation, pork cultivation, exotic & novel meats, and others. Poultry cultivation generated USD 74.3 million revenue in 2024 and is anticipated to expand at a CAGR of 3.4% during 2025 to 2034, holding a market share of 42% in 2024.
 

• Poultry cultivation dominates the cultivated meat ingredients market due to its favorable biological characteristics and accelerated commercialization pathway compared to other meat types. The advantages of poultry cell cultivation stem from faster cell doubling times (18-24 hours versus 24-48 hours for mammalian cells), lower media complexity requirements, and established consumer acceptance of processed chicken products that align with cultivated meat formats. These characteristics make poultry cultivation particularly attractive for first-generation commercial production facilities where rapid scale-up, reduced capital intensity, and shorter time-to-market are critical success factors for achieving economic sustainability.
   
• Poultry cultivation has established leadership through its versatility in meeting diverse product format requirements across multiple consumer segments and distribution channels. By utilizing optimized media formulations and scaffold-free production techniques, manufacturers can develop cultivated chicken products ranging from ground applications (nuggets, patties, sausages) to structured formats (breast strips, whole-muscle analogs) to match exact market specifications. This product flexibility has enabled poultry cultivation to capture approximately 42% of the total ingredient market, significantly outperforming beef, seafood, and pork alternatives in attracting investment capital, regulatory approvals, and commercial production commitments from leading cultivated meat companies worldwide.
   

Based on end use, the market is segmented into commercial cultivated meat producers, pilot & demonstration facilities, research institutions & academia, and others. Commercial cultivated meat producers generated USD 123.9 million revenue in 2024 and is anticipated to expand at a CAGR of 3.3% during 2025 to 2034, holding a market share of 70% in 2024.
 

• Commercial cultivated meat producers dominate the cultivated meat ingredients market due to their large-scale production requirements and sustained operational demand for consistent ingredient supply. The advantages of commercial producers stem from their established bioreactor infrastructure (ranging from 2,000 to 50,000+ liter capacity), standardized production protocols requiring bulk ingredient volumes, and long-term procurement contracts that ensure predictable revenue streams for ingredient suppliers. These characteristics make commercial producers particularly critical for driving ingredient market growth where economies of scale, supply chain reliability, and quality assurance standards are fundamental requirements for maintaining continuous production operations and meeting regulatory compliance obligations.
   
• Commercial cultivated meat producers have established leadership through their capacity to absorb significant ingredient volumes across multiple production cycles and product lines simultaneously. By implementing advanced bioprocessing systems and automated media preparation facilities, commercial producers can utilize optimized ingredient formulations at industrial scale to achieve target production metrics including cell density thresholds, tissue yield specifications, and cost-per-kilogram targets to match exact commercial viability requirements. This operational scale has enabled commercial producers to capture approximately 70% of the total ingredient market, significantly outperforming pilot facilities, research institutions, and other end user categories in driving demand for growth media components, scaffolding materials, and processing aids essential for transitioning cultivated meat from laboratory innovation to mainstream food production infrastructure.

The cultivated meat ingredients market in North America will grow at a CAGR of approximately 3.3% between 2025 and 2034.
 

• Rising awareness at the corporate level about sustainable protein production and cellular agriculture principles influences the regional drive for cultivated meat ingredients in commercial production facilities, pilot-scale operations, and research applications. At the same time, increasing concerns for animal welfare and environmental sustainability have been commencing optimistic trends for advanced bioprocessing technologies to gradually complement conventional meat production and traditional animal agriculture methods.
   
• Unique precision fermentation systems and recombinant protein innovations epitomize the technical evolution into enhanced efficiency of growth media formulation processes together with cost reduction and scalability benefits, making the industrial future of cellular agriculture viable, e.g., in the upcoming era of commercial cultivated meat production, hybrid product development, and alternative protein manufacturing applications.
   

The cultivated meat ingredients market in Europe, especially in a few countries like Germany, is expected to grow with a rapid pace in the coming years, especially from 2025 to 2034, with CAGR of 3.1%.
 

• Stringent food safety regulations along with established knowledge of novel food approval pathways have observed an incline in cultivated meat ingredient preference; such incline further augurs well for the growth media components and scaffolding materials market.
   
• R&D explorations of better serum-free media technologies and process optimization in bioreactor and cell culture modes have surged forth with admittable efficiency and expanded ingredient applications, especially in structured meat products and whole-cut cultivated formats.
   
• The European market propagated by the Farm to Fork strategy and Green Deal initiatives only certifies animal-free ingredients in sustainable food manufacturing formulations and in the process widens market opportunities in a broad spectrum of sectors. Higher investment in R&D and in cellular agriculture infrastructure development is expanding the product applications of cultivated meat ingredient materials.
   

The cultivated meat ingredients market in China and India is expected to have lucrative growth between 2025 and 2034, with CAGR of 3.5% in the Asia Pacific region.
 

• Demand is fueled with a burgeoning cellular agriculture sector and spurt in alternative protein manufacturing, looking for high-quality growth media components and scaffolding materials produced through advanced precision fermentation technology.
   
• On-going government policies toward food security initiatives and sustainable protein production practices further pour in capital investment for the clean production methods with ingredient manufacturing facilities.
   
• Due to the increasing cultivated meat consumption interest and health-conscious consumer markets, Asia Pacific continues utilizing such technologies, with counting on advancements in the ingredient manufacturing and bioprocessing applications.
   

Between 2025 and 2034, a promising expansion of the cultivated meat ingredients sector is foreseen in the Latin America with CAGR of 3.1%.
 

• High alternative protein industry growth already enjoys their consideration for sustainable and innovative protein production technologies as interest-worthy, encouraging the use of cultivated meat ingredient technology.
   
• Awareness is multiplying for the benefits of cellular agriculture through precision fermentation technology, and it is now gaining considerable industrial understanding, much in commercial production facilities and pilot-scale operations.
   
• The tremendous boost to cultivated meat ingredient technology by laws aimed at encouraging sustainable food production and innovative methods of protein sourcing, everything appears to be nothing but optimism in the development for that technology in Latin America.
   

Between 2025 and 2034, the Middle East & Africa (MEA) cultivated meat ingredients market is projected to grow strongly, with a CAGR of around 2.9%, driven by rising interest in sustainable protein solutions.
 

• The Middle East & Africa region is experiencing rising pressure on local protein supply due to high reliance on imports, pushing governments and industries to explore alternative domestic protein sources such as cultivated meat ingredients and cellular agriculture technologies.
   
• Fast-growing food security programs, alternative protein initiatives, and sustainable agriculture sectors, especially in UAE, Saudi Arabia, Israel, and South Africa, are driving demand for functional, scalable ingredients that enhance production efficiency—making growth media components and scaffolding materials increasingly relevant.
   
• Strategic government investments in food technology innovation, particularly from large-scale facilities and wholesale production commitments, are motivating investment in precision fermentation technologies to improve sustainability performance and reduce import dependencies.
   

Cultivated Meat Ingredients Market Share

In 2024, the global cultivated meat ingredients industry was led by a diverse group of life sciences companies, bioprocessing specialists, and precision fermentation firms, where the top five companies collectively accounted for approximately 38.5% of the market share in 2024, including Thermo Fisher Scientific, Merck KGaA, Sartorius AG, Evonik Industries, and CJ CheilJedang. These companies hold strong market positions due to their advanced precision fermentation technologies, integrated bioprocessing systems, recombinant protein production capabilities, and strategic partnerships with cultivated meat producers, enabling efficient media formulation, scaffold material development, and functional ingredient optimization.
 

• Thermo Fisher Scientific is a leading American life sciences company headquartered in Waltham, Massachusetts, specializing in cell culture media and bioprocessing solutions with proprietary serum-free formulations that support animal cell cultivation across pharmaceutical and food technology applications. The company operates advanced manufacturing facilities producing growth media components, recombinant proteins, and specialized supplements while maintaining extensive quality documentation for GMP compliance and food-grade specifications, positioning itself as a pioneer in transitioning pharmaceutical-grade cell culture technologies to cultivated meat production and cellular agriculture innovation.
   
• Merck KGaA operates specialized bioprocessing ingredient manufacturing facilities globally, focusing on amino acid production, growth factor development, and media component supply with annual production capacity handling diverse cell culture applications including mammalian, avian, and aquatic cell lines. The company recently expanded its food-grade ingredient portfolio with targeted formulations for cultivated meat applications and maintains integrated supply chain operations from fermentation facilities to distribution networks, serving as a critical supplier to the global cellular agriculture and bioprocessing sectors with established customer relationships across commercial producers, pilot facilities, and research institutions.
   
• Bio-Techne  is a premier biotechnology company based in Minneapolis, Minnesota, processing recombinant growth factors and cytokines through specialized protein expression systems. The company focuses exclusively on high-purity bioactive protein production operations, maintaining advanced quality control systems and established manufacturing protocols that enable efficient recombinant protein production supporting the cultivated meat research and development markets with specialized growth factors including FGF, IGF, TGF-beta, and PDGF families.
   

Cultivated Meat Ingredients Market Companies

The major players operating in cultivated meat ingredients industry include:
 

• Thermo Fisher Scientific
• Merck KGaA
• Bio-Techne
• Ajinomoto
• Evonik Industries
• CJ Bio
• Wacker Chemie
• Sartorius
• ADM
• Cargill
• GenScript
• Takara Bio
• Rousselot
• GELITA
• Palsgaard
   

Cultivated Meat Ingredients Industry News

• In May 2025, Multus Biotechnology has launched DMEM/F12-FG, a new food-grade basal media designed for scalable, regulatory-compliant cultivated meat production. Developed in collaboration with global food and feed ingredient companies, the formulation delivers essential nutrients while leveraging AI to replace biopharma-grade components with food-industry alternatives.
   
• In February 2025, Meatly has launched the world’s first cultivated pet food, debuting “Chick Bites” in partnership with plant-based dog food brand THE PACK. The limited-release treats, available at Pets at Home Brentford in London, combine plant-based ingredients with Meatly’s cultivated chicken made from a single egg-derived cell sample.
   

The cultivated meat ingredients market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue (USD Million) & (Kilo Tons) from 2021 to 2034, for the following segments:

Click here to Buy Section of this Report

Market, By Ingredients

• Growth media components   
  • Basal media
  • Serum & serum alternatives
  • Recombinant growth factors
  • Recombinant structural & functional proteins
  • Amino acids & nitrogen sources
  • Vitamins, minerals & energy sources
• Growth media components   
  • Nanofibrous scaffolds
  • Edible microcarriers
  • Edible membranes & hollow fiber systems
  • Extracellular matrix (ECM) proteins
  • Plant-derived scaffolds
  • Fungal & microbial scaffolds
  • Synthetic polymer scaffolds
  • 3D bioinks
• Processing aids & formulation ingredients    
  • Crosslinking enzymes
  • Lipids & fatty acids
  • Emulsifiers & stabilizers
  • Fat substitutes & oleogels
  • Flavor systems & sensory enhancers

Market, By Application

• Poultry cultivation,
• Seafood & fish cultivation
• Beef & red meat cultivation
• Pork cultivation
• Exotic & novel meats
• Others

Market, By End Use

• Commercial cultivated meat producers
• Pilot & demonstration facilities
• Research institutions & academia
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of Asia Pacific 
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America 
• MEA
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East and Africa